New Delhi: AIIMS Delhi will start human trials of Covaxin — country’s first indigenous COVID-19 vaccine — next week with 100 healthy volunteers in the age group of 18-55 years.
For a period of 150 days the volunteers will be kept under observation. The vaccine has been developed by Bharat Biotech collaborating with Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
“We will begin human trials of India’s first indigenous vaccine, Covaxin, on 100 healthy volunteers aged between 18 and 55 years. We will ensure that none of the volunteers have any comorbidities. AIIMS will conduct trials on 100 volunteers out of a total of 375 persons,” Professor of Community Medicine and Principal Investigator of COVID-19 vaccine trial, Sanjay Rai was quoted as saying by news agency IANS.
New Delhi: After the record-breaking success of ‘Pushpa 2: The Rule’, Rashmika Mandanna has her…
Bhubaneswar: Twelve members of Village Water and Sanitation Committees (VWSC) from nine districts of Odisha…
Hyderabad: Bollywood actress Janhvi Kapoor, who is rumoured to be dating Shikhar Pahariya, had once…
Bhubaneswar: In a remarkable stride toward strengthening industrial ecosystem, the Odisha government on Wednesday approved…
Bengaluru: Playing away from home, Odisha FC turned the game on its head to snatch a…
Hyderabad: Two weeks after its Telugu release, the Hindi version of Balakrishna-Urvashi Rautela starrer ‘Daaku…
This website uses cookies.
